Vaginal fluid test study for endometrial cancer detection
Part of Cancer, Women’s health & pregnancy clinical trials.
This study tests whether a simple vaginal fluid sample can help detect endometrial cancer (cancer of the uterus lining) or precancerous changes. You'll provide a vaginal specimen alongside your standard medical care, helping researchers develop a non-invasive screening tool.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old (or 45+ for one part of the study)
- You either have abnormal uterine bleeding being investigated OR a newly confirmed diagnosis of endometrial cancer or precancerous endometrial changes
- You have not had your uterus removed (hysterectomy)
- You are not currently pregnant
- You have not had pelvic or vaginal radiation therapy in the past
- You have not received chemotherapy in the past 5 years (except tamoxifen for breast cancer)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a simple, non-invasive method to detect endometrial cancer in women after menopause who have abnormal bleeding. It aims to find cancer early in those at higher risk, such as women with certain genetic conditions or risk factors.
This study looks for “methylated DNA markers” (special DNA patterns) to help detect endometrial, ovarian, and cervical cancers, and to support doctors around planned procedures. It may help find cancer earlier or better sort out who needs closer treatment.
This study uses a risk model to detect endometrial cancer in people with unexplained abnormal uterine bleeding. It aims to find better ways to identify cancer early without relying only on invasive biopsies.
This study tests if a DNA test in urine and vaginal samples you collect at home can help find endometrial cancer. It compares results from people with the cancer to healthy volunteers.
This study measures hormones in urine to understand why some women have abnormal uterine bleeding and whether it increases cancer risk. It may help doctors better predict and prevent uterine cancer in the future.
This study tests a new device that collects a sample from the vagina to see if it can find endometrial (uterine) or ovarian cancers. If you are seeing a gynecologist and can tolerate a speculum or tampon, you may be able to help.
Hear when a new Endometrial Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.